Re: Machida et al. Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion? J Oncol Pharm Pract. DOI: 10.1177/1078155218791323 Shared decision making can aid the informed consent process for end-of-life chemotherapy in cancer patients

Gilbar Peter

首页> 外文期刊>Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners >Re: Machida et al. Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion? J Oncol Pharm Pract. DOI: 10.1177/1078155218791323 Shared decision making can aid the informed consent process for end-of-life chemotherapy in cancer patients

【24h】

Re: Machida et al. Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion? J Oncol Pharm Pract. DOI: 10.1177/1078155218791323 Shared decision making can aid the informed consent process for end-of-life chemotherapy in cancer patients

机译：回复：machida等。知情同意癌症患者的生活终末化疗：我们应该在多大程度上向患者提供个人意见？ j onpol pharm实践。 DOI：10.1177 / 10781555218791323共享决策可以帮助癌症患者的生活终生化疗的知情同意过程

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners》 |2019年第1期|共2页
作者
Gilbar Peter;
展开▼
作者单位

Toowoomba Hosp PMB 2 Toowoomba Qld 4350 Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
专利

1. Re: Machida et al. Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion? J Oncol Pharm Pract. DOI: 10.1177/1078155218791323 Shared decision making can aid the informed consent process for end-of-life chemotherapy in cancer patients [J] . Gilbar Peter Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2019,第1期

机译：回复：machida等。知情同意癌症患者的生活终末化疗：我们应该在多大程度上向患者提供个人意见？ j onpol pharm实践。 DOI：10.1177 / 10781555218791323共享决策可以帮助癌症患者的生活终生化疗的知情同意过程
2. Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. [J] . Derya Hopanci Bicakli, Umut Varol, Mustafa Degirmenci, Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2015,第4期

机译：回复编辑，Re：Bicakli等。辅助化疗可能会增加乳腺癌患者发生代谢综合征的风险。 J Oncol Pharm Pract，在线发表于2014年9月。DOI：10.1177 / 1078155214551315。
3. Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. [J] . Mehmet Agilli, Fevzi Nuri Aydin Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2015,第4期

机译：回复：Bicakli等。辅助化疗可能会增加乳腺癌患者发生代谢综合征的风险。 J Oncol Pharm Pract，在线发表于2014年9月。DOI：10.1177 / 1078155214551315。
4. The discourse of advance care planning: End-of-life decision-making in a multicultural population of cancer and AIDS patients. [D] . Drought, Theresa Sue. 2000

机译：预先护理计划的论述：癌症和艾滋病患者的多元文化群体中的生命终结决策。
5. Surrogate decision making of chemotherapy consent: do we really provide informed consent of chemotherapy for patients? [O] . Jung Hye Kwon, Sun Kyung Baek, Bong-Seog Kim, 2019

机译：替代化疗同意的决策：我们是否真的为患者提供了化疗的知情同意？
6. Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion? [O] . Shizuo Machida, Shigeki Matsubara, Hiroyuki Fujiwara, 2018

机译：知情同意癌症患者的生活终末化疗：我们应该在多大程度上向患者提供个人意见？

著录项

相似文献

相关主题

期刊订阅